ATC/DDD

ATC/DDD index J01FA

You are here: Home > ATC/DDD > J > J01 > J01F

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- J
ANTIINFECTIVES FOR SYSTEMIC USE
- J01
ANTIBACTERIALS FOR SYSTEMIC USE
- J01F
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS

J01FA

Macrolides

ATC/DDD code J01FA for Macrolides

Erythromycin ethylsuccinate has been assigned a higher DDD than other preparations of erythromycin due to a lower bioavailability.

This DDD is mainly based on the dose recommendations.

The oral DDD for azithromycin is based on a 5-day regimen.

J01FA01
Erythromycin
J01FA02
Spiramycin
J01FA03
Midecamycin
J01FA05
Oleandomycin
J01FA06
Roxithromycin
J01FA07
Josamycin
J01FA08
Troleandomycin
J01FA09
Clarithromycin
J01FA10
Azithromycin
J01FA11
Miocamycin
J01FA12
Rokitamycin
J01FA13
Dirithromycin
J01FA14
Flurithromycin
J01FA15
Telithromycin
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us